Distribution of Pathogenic Yeasts in Different Clinical Samples: Their Identification, Antifungal Susceptibility Pattern, and Cell Invasion Assays

References

• Pappas PG, Lionakis MS, Arendrup MC, et al. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026. doi:10.1038/nrdp.2018.2629749387
   PubMed Web of Science ®Google Scholar
• Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp. among Candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14:e954–e966. doi:10.1016/j.ijid.2010.04.00620797887
   PubMed Web of Science ®Google Scholar
• Schwartz IS, Patterson TF. The emerging threat of antifungal resistance in transplant infectious diseases. Curr Infect Dis Rep. 2018;20(3):2. doi:10.1007/s11908-018-0608-y29404711
   PubMed Web of Science ®Google Scholar
• Paolucci M, Landini MP, Sambri V. How can the microbiologist help in diagnosing neonatal sepsis? Int J Pediatr. 2012;120139.
   Google Scholar
• He S, Hang JP, Zhang L, et al. A systematic review and meta-analysis of diagnostic accuracy of serum 1, 3-β-D-glucan for invasive fungal infection: focus on cut off levels. J Microbiol Immunol Infect. 2015;48:351–361. doi:10.1016/j.jmii.2014.06.00925081986
   PubMedGoogle Scholar
• Williams DW, Lewis MAO. Isolation and identification of Candida from the oral cavity. ISRN Dent. 2000;3–11.
   Google Scholar
• Zhang J, Hung GC, Nagamine K, et al. Development of Candida-specific real-time PCR assays for the detection and identification of eight medically important Candida species. Microbiol Insights. 2016;9:21–28. doi:10.4137/MBI.S3851727103821
   PubMedGoogle Scholar
• Avni T, Leibovici L, Paul M. PCR diagnosis of invasive Candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2011;49:665–670. doi:10.1128/JCM.01602-1021106797
   PubMed Web of Science ®Google Scholar
• Brinkman NE, Haugland RA, Wymer LJ, et al. Evaluation of a rapid, quantitative real-time PCR method for enumeration of pathogenic Candida cells in water. Appl Environ Microbiol. 2003;69:1775–1782. doi:10.1128/AEM.69.3.1775-1782.200312620869
   PubMed Web of Science ®Google Scholar
• Mirhendi H, Makimura K, Khoramizadeh M, et al. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi. 2006;47:225–229. doi:10.3314/jjmm.47.22516940958
   PubMedGoogle Scholar
• Raja HA, Miller AN, Pearce CJ, et al. Fungal identification using molecular tools: a primer for the natural products research community. J Nat Prod. 2017;80:756–770. doi:10.1021/acs.jnatprod.6b0108528199101
   PubMed Web of Science ®Google Scholar
• Lacroix C, Gicquel A, Sendid B, et al. Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species. Clin Microbiol Infect. 2014;20:153–158. doi:10.1111/1469-0691.1221023594150
   PubMed Web of Science ®Google Scholar
• Qian J, Cutler JE, Cole RB, et al. MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal Bioanal Chem. 2008;392:439–449. doi:10.1007/s00216-008-2288-118690424
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Houston A, Coffmann S. Application of CHROM agar candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol. 1996;34:58–61. doi:10.1128/JCM.34.1.58-61.19968748273
   PubMed Web of Science ®Google Scholar
• Basu S, Gugnani HC, Joshi S, et al. Distribution of Candida species in different clinical sources in Delhi, India, and proteinase and phospholipase activity of Candida albicansisolates. Rev Iberoam Micol. 2003;20:137–140.15456350
   PubMedGoogle Scholar
• Mohandas V, Ballal M. Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in Southern India. J Glob Infect Dis. 2011;3:4. doi:10.4103/0974-777X.7728821572601
   PubMedGoogle Scholar
• Kaur R, Dhakad MS, Goyal R, et al. Emergence of non-albicans Candida species and antifungal resistance in intensive care unit patients. Asian Pac J Trop Biomed. 2016;6:455–460. doi:10.1016/j.apjtb.2015.12.019
   Web of Science ®Google Scholar
• Bhattacharjee P. Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India. Curr. Med. Mycol. 2016;2. doi:10.18869/acadpub.cmm.2.2.5
   Google Scholar
• Boratyn GM, Camacho C, Cooper PS, et al. BLAST: a more efficient report with usability improvements. Nucleic Acids Res. 2013;41:W29–33. doi:10.1093/nar/gkt28223609542
   PubMed Web of Science ®Google Scholar
• Larone DH. Medically Important Fungi: A Guide to Identification. 4th ed. Washington D.C: American Society for Microbiology Press; 2002:409.
   Google Scholar
• Kumar S, Stecher G, Tamura K. MEGA7: molecular Evolutionary Genetics Analysis Version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–1874. doi:10.1093/molbev/msw05427004904
   PubMed Web of Science ®Google Scholar
• Chao QT, Lee TF, Teng SH, et al. Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts. PLoS One. 2014;9:e109376. doi:10.1371/journal.pone.010937625330370
   PubMed Web of Science ®Google Scholar
• Stevenson LG, Drake SK, Shea YR, et al. Evaluation of matrix-assisted laser desorption ionization - Time of flight mass spectrometry for identification of clinically important yeast species. J Clin Microbiol. 2010;48:3482–3486. doi:10.1128/JCM.00687-0920668126
   PubMed Web of Science ®Google Scholar
• Mancini N, De Carolis E, Infurnari L, et al. Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass Spectrometry systems for identification of yeasts of medical importance. J Clin Microbiol. 2013;51:2453–2457. doi:10.1128/JCM.00841-1323678071
   PubMed Web of Science ®Google Scholar
• Sendid B, Ducoroy P, François N, et al. Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals. Med Mycol. 2013;51:25–32. doi:10.3109/13693786.2012.69363122703164
   PubMed Web of Science ®Google Scholar
• Westblade LF, Jennemann R, Branda JA, et al. Multicenter study evaluating the Vitek MS system for identification of medically important yeasts. J Clin Microbiol. 2013;51:2267–2272. doi:10.1128/JCM.00680-1323658267
   PubMed Web of Science ®Google Scholar
• Hamprecht A, Christ S, Oestreicher T, et al. Performance of two MALDI-TOF MS systems for the identification of yeasts isolated from bloodstream infections and cerebrospinal fluids using a time-saving direct transfer protocol. Med Microbiol Immunol. 2014;203:93–99. doi:10.1007/s00430-013-0319-924310420
   PubMed Web of Science ®Google Scholar
• Li MC, Chang TC, Chen HM, et al. Oligonucleotide array and VITEK matrix-assisted laser desorption ionization-time of flight mass spectrometry in species identification of blood yeast isolates. Front Microbiol. 2018;9:1–7. doi:10.3389/fmicb.2018.0000129403456
   PubMed Web of Science ®Google Scholar
• Rahi P, Prakash O, Shouche YS. Matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry (MALDI-TOF MS) based microbial identifications: challenges and scopes for microbial ecologists. Front Microbiol. 2016;7:1359. doi:10.3389/fmicb.2016.0135927625644
   PubMed Web of Science ®Google Scholar
• Liu H, Du Z, Wang J, Yang R. Universal sample preparation method for characterization of bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol. 2007;73:1899–1907. doi:10.1128/AEM.02391-0617277202
   PubMed Web of Science ®Google Scholar
• Freiwald A, Sauer S. Phylogenetic classification and identification of bacteria by mass spectrometry. Nat Protoc. 2009;4(5):732–742. doi:10.1038/nprot.2009.3719390529
   PubMed Web of Science ®Google Scholar
• Faria-Ramos I, Neves-Maia J, Ricardo E, et al. Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey. Eur J Clin Microbiol Infect Dis. 2014;33(12):2241–2247. doi:10.1007/s10096-014-2194-825012821
   PubMed Web of Science ®Google Scholar
• Guinea J, Zaragoza Ó, Escribano P, et al. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother. 2014;58(3):1529–1537. doi:10.1128/AAC.02155-1324366741
   PubMed Web of Science ®Google Scholar
• Minea B, Nastasa V, Moraru RF, et al. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study. Eur J Clin Microbiol Infect Dis. 2014;34:367–383. doi:10.1007/s10096-014-2240-625224578
   PubMed Web of Science ®Google Scholar
• Orasch C, Marchetti O, Garbino J, et al. Candida species distribution and antifungal susceptibility testing according to European committee on antimicrobial susceptibility Testing and new vs. old clinical and laboratory standards institute clinical breakpoints: a 6-year prospective candidaemia’s. Clin Microbiol Infect. 2014;20:698–705. doi:10.1111/1469-0691.1244024188136
   PubMed Web of Science ®Google Scholar
• Meletiadis J, Curfs-Breuker I, Meis JF, et al. In vitro antifungal susceptibility testing of Candida isolates with the EUCAST methodology, a new method for ECOFF determination. Antimicrob Agents Chemother. 2017;61:1–6. doi:10.1128/AAC.02372-16
   Web of Science ®Google Scholar
• Bernhardt J, Bernhardt H, Knoke M, et al. Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans. Mycoses. 2004;47:330–337. doi:10.1111/j.1439-0507.2004.01004.x15310340
   PubMed Web of Science ®Google Scholar
• Wächtler B, Wilson D, Hube B. Candida albicans adhesion, invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole. Antimicrob Agents Chemother. 2011;55(9):4436–4439. doi:10.1128/AAC.00144-1121746947
   PubMed Web of Science ®Google Scholar
• Martins HP, Da Silva MC, Paiva LC, et al. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. Acta Derm Venereol. 2012;92:78–82.21918792
   PubMed Web of Science ®Google Scholar
• Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida Species. Front Microbiol. 2017;7:2173. doi:10.3389/fmicb.2016.0217328127295
   PubMed Web of Science ®Google Scholar
• Castanheira M, Messer SA, Jones RN, Farrell DJ, Pfaller MA. Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections. Int J Antimicrob Agents. 2014;44:320–326. doi:10.1016/j.ijantimicag.2014.06.00725129315
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol. 2012;50:1199–1203. doi:10.1128/JCM.06112-1122278842
   PubMed Web of Science ®Google Scholar
• Cho EJ, Shin JH, Kim SH, et al. Emergence of multiple resistance profiles involving azoles, echinocandins and amphotericin B in Candida glabrata isolates from a neutropenia patient with prolonged fungaemia. J Antimicrob Chemother. 2015;70:1268–1270. doi:10.1093/jac/dku51825550394
   PubMed Web of Science ®Google Scholar
• Sun JN, Solis NV, Phan QT, et al. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog. 2010;6(11):e1001181. doi:10.1371/journal.ppat.100118121085601
   PubMed Web of Science ®Google Scholar
• Villar CC, Kashleva H, Mitchell AP, et al. Invasive phenotype of Candida albicans affects the host pro-inflammatory response to infection. Infect Immun. 2005;73(8):4588–4595. doi:10.1128/IAI.73.8.4588-4595.200516040970
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2016;374:794–795. doi:10.1056/NEJMc1514201
   PubMedGoogle Scholar
• Romeo O, Tietz HJ, Criseo G. Candida africana: is it a fungal pathogen? Curr Fungal Infect Rep. 2013;7:192–197. doi:10.1007/s12281-013-0142-1
   Google Scholar
• Borman AM, Szekely A, Linton CJ, et al. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. J Clin Microbiol. 2013;51:967–972. doi:10.1128/JCM.02816-1223303503
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Biswas SK, Miyaji M, Nishimura K. Identification and phylogenetic relationship of the most common pathogenic Candida species inferred from mitochondrial cytochrome b gene sequences. J Clin Microbiol. 2000;38:4503–4510. doi:10.1128/JCM.38.12.4503-4510.200011101587
   PubMed Web of Science ®Google Scholar
• Aubertine CL, Rivera M, Rohan SM, et al. Comparative study of the new colorimetric VITEK 2 yeast identification card versus the older fluorometric card and of CHROM agar Candida as a source medium with the new card. J Clin Microbiol. 2006;44:227–228. doi:10.1128/JCM.44.1.227-228.200616390976
   PubMed Web of Science ®Google Scholar
• Wang H, Fan YY, Kudinha T, et al. A comprehensive evaluation of the Bruker Biotyper MS and Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass spectrometry systems for identification of yeasts, part of the national China hospital invasive fungal surveillance net (CHIF-NET). J Clin Microbiol. 2016;54:1376–1380. doi:10.1128/JCM.00162-1626912761
   PubMed Web of Science ®Google Scholar
• Clancy CJ, Nguyen MH. Diagnosing invasive candidiasis. J Clin Microbiol. 2018;56:e01909–17. doi:10.1128/JCM.01909-1729444828
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13(5):e1006290. doi:10.1371/journal.ppat.100629028542486
   PubMed Web of Science ®Google Scholar
• Eddouzi J, Hofstetter V, Groenewald M. Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection of Tunisian hospitals. J Clin Microbiol. 2012;17:JCM–01627.
   Google Scholar
• Pote ST, Chakraborty A, Lahiri KK, et al. Keratitis by a rare pathogen Colletotrichum gloeosporioides: a case report. J. Mycol Med. 2017;27:407–411. doi:10.1016/j.mycmed.2017.04.00928501467
   PubMed Web of Science ®Google Scholar
• Pote ST, Khan U, Lahiri KK, et al. Onychomycosis due to Achaetomium strumarium. J. Mycol Med. 2018;28:510–513. doi:10.1016/j.mycmed.2018.07.00230104134
   PubMed Web of Science ®Google Scholar
• Brandt ME, Lockhart SR. Recent taxonomic developments with Candida and other opportunistic yeasts. Curr Fungal Infect Rep. 2012;6(3):170–177. doi:10.1007/s12281-012-0094-x26526658
   PubMedGoogle Scholar
• Sharma R, Shouche Y. Nannizzia graeserae sp. nov., a new dermatophyte of geophilic clade isolated from vicinity of a barbershop in India. Kavaka. 2018;50:14–20.
   Google Scholar